Comprehensive, easy-to-understand information about this condition
How we create this content →The documentation for chromosome 17P13.3, telomeric, duplication syndrome is limited due to its rarity and the lack of systematic clinical studies. Conditions like this often affect fewer individuals, which can hinder comprehensive research and characterization. Additionally, the absence of identified genes complicates the understanding of the condition's etiology and management. Despite these challenges, ongoing efforts in rare disease research may provide more insights in the future.
The clinical features of chromosome 17P13.3, telomeric, duplication syndrome primarily affect the limbs. The most common manifestations include split hand malformations (30-79% frequency) and short tibia (30-79%). Other notable features include contractures of the proximal interphalangeal joints of the fingers, particularly the 4th and 3rd fingers (30-79% and 5-29% frequency, respectively). Brachydactyly and absent hallux are also observed, with the latter occurring in 5-29% of cases. These features highlight the need for multidisciplinary management and support.
To navigate the complexities of chromosome 17P13.3, telomeric, duplication syndrome, consider consulting a geneticist or a specialist in genetic disorders. They can provide insights into potential genetic counseling and family planning options. While there are currently no patient organizations specific to this condition, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov may offer valuable information. Additionally, participating in natural history studies could contribute to the understanding of this condition, so inquire about any available opportunities.
Actionable guidance for navigating care for chromosome 17P13.3, telomeric, duplication syndrome
To navigate the complexities of chromosome 17P13.3, telomeric, duplication syndrome, consider consulting a geneticist or a specialist in genetic disorders. They can provide insights into potential genetic counseling and family planning options. While there are currently no patient organizations specific to this condition, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov may offer valuable information. Additionally, participating in natural history studies could contribute to the understanding of this condition, so inquire about any available opportunities.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation for chromosome 17P13.3, telomeric, duplication syndrome is limited due to its rarity and the lack of systematic clinical studies. Conditions like this often affect fewer individuals, which can hinder comprehensive research and characterization. Additionally, the absence of identified genes complicates the understanding of the condition's etiology and management. Despite these challenges, ongoing efforts in rare disease research may provide more insights in the future.
The clinical features of chromosome 17P13.3, telomeric, duplication syndrome primarily affect the limbs. The most common manifestations include split hand malformations (30-79% frequency) and short tibia (30-79%). Other notable features include contractures of the proximal interphalangeal joints of the fingers, particularly the 4th and 3rd fingers (30-79% and 5-29% frequency, respectively). Brachydactyly and absent hallux are also observed, with the latter occurring in 5-29% of cases. These features highlight the need for multidisciplinary management and support.
To navigate the complexities of chromosome 17P13.3, telomeric, duplication syndrome, consider consulting a geneticist or a specialist in genetic disorders. They can provide insights into potential genetic counseling and family planning options. While there are currently no patient organizations specific to this condition, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov may offer valuable information. Additionally, participating in natural history studies could contribute to the understanding of this condition, so inquire about any available opportunities.
Actionable guidance for navigating care for chromosome 17P13.3, telomeric, duplication syndrome
To navigate the complexities of chromosome 17P13.3, telomeric, duplication syndrome, consider consulting a geneticist or a specialist in genetic disorders. They can provide insights into potential genetic counseling and family planning options. While there are currently no patient organizations specific to this condition, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov may offer valuable information. Additionally, participating in natural history studies could contribute to the understanding of this condition, so inquire about any available opportunities.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation for chromosome 17P13.3, telomeric, duplication syndrome is limited due to its rarity and the lack of systematic clinical studies. Conditions like this often affect fewer individuals, which can hinder comprehensive research and characterization. Additionally, the absence of identified genes complicates the understanding of the condition's etiology and management. Despite these challenges, ongoing efforts in rare disease research may provide more insights in the future.
The clinical features of chromosome 17P13.3, telomeric, duplication syndrome primarily affect the limbs. The most common manifestations include split hand malformations (30-79% frequency) and short tibia (30-79%). Other notable features include contractures of the proximal interphalangeal joints of the fingers, particularly the 4th and 3rd fingers (30-79% and 5-29% frequency, respectively). Brachydactyly and absent hallux are also observed, with the latter occurring in 5-29% of cases. These features highlight the need for multidisciplinary management and support.
To navigate the complexities of chromosome 17P13.3, telomeric, duplication syndrome, consider consulting a geneticist or a specialist in genetic disorders. They can provide insights into potential genetic counseling and family planning options. While there are currently no patient organizations specific to this condition, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov may offer valuable information. Additionally, participating in natural history studies could contribute to the understanding of this condition, so inquire about any available opportunities.
Actionable guidance for navigating care for chromosome 17P13.3, telomeric, duplication syndrome
To navigate the complexities of chromosome 17P13.3, telomeric, duplication syndrome, consider consulting a geneticist or a specialist in genetic disorders. They can provide insights into potential genetic counseling and family planning options. While there are currently no patient organizations specific to this condition, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov may offer valuable information. Additionally, participating in natural history studies could contribute to the understanding of this condition, so inquire about any available opportunities.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.